Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Ertapenem:Susc:Pt:Isolate:OrdQn:MIC

Known as: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC), Ertapenem:Susc:Pt:Isolato:OrdQn:MIC, Ertapenem:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Minimum Inhibitory Concentration 
National Institutes of Health

Related topics

Related topics

3 relations
Isolate - microorganismMinimum Inhibitory Concentration measurementertapenem

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
NT 1153 - 2019 - Osteomielite Ertapenem - NATJUS TJMG
2016
2016
Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae
ABSTRACT The minimal concentration of antibiotic required to inhibit the growth of different isolates of a given species with no… 
2015
2015
Informe Ertapenem 1 g inyectable
2015
2015
Informe técnico ertapenem 1g inyectable
2013
2013
Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
ABSTRACT Enterobacteriaceae producing the OXA-48 carbapenemase are emerging worldwide, leaving few treatment options. Efficacy… 
  • table 1
  • figure 1
  • figure 2
2012
2012
Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
ABSTRACT A retrospective study was conducted at two medical centers in Taiwan to evaluate the clinical characteristics, outcomes… 
2011
2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae… 
  • table 1
  • table 2
  • table 3
  • table 4
2009
2009
Different sample stacking strategies for the determination of ertapenem and its impurities by micellar electrokinetic chromatography in pharmaceutical formulation.
Ertapenem, a Group 1 carbapenem, is most recently introduced into the market. It is a beta-lactam antibiotic that possesses a… 
2007
2007
Course of transplant recipients treated with Ertapenem in the prophylaxis and treatment of infections: a first experience
ZusammenfassungGRUNDLAGEN: Infektionen sind die häufigsten Komplikationen nach Organtransplantationen. Bakterien gehören zu den h… 
2002
2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
This study compared the in vitro activities of ertapenem (Merck & Co., Inc.), ceftriaxone, amoxicillin-clavulanate, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE